Home/Filings/4/0001104659-20-033114
4//SEC Filing

Lorenz Kevin 4

Accession 0001104659-20-033114

CIK 0001429260other

Filed

Mar 12, 8:00 PM ET

Accepted

Mar 13, 4:07 PM ET

Size

5.0 KB

Accession

0001104659-20-033114

Insider Transaction Report

Form 4
Period: 2020-01-01
Lorenz Kevin
Director
Transactions
  • Purchase

    COMMON STOCK, PAR VALUE $0.001

    2020-01-01+50,000164,582 total
Footnotes (2)
  • [F1]One-third of the shares will vest on each of January 1, 2021, 2022 and 2023, subject to continued service.
  • [F2]Includes 34,582 shares owned by Mr. Lorenz prior to his appointment to the Company's board in August 2019.

Issuer

Fortress Biotech, Inc.

CIK 0001429260

Entity typeother

Related Parties

1
  • filerCIK 0001772558

Filing Metadata

Form type
4
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 4:07 PM ET
Size
5.0 KB